AtriCure Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	518.31	465.31	399.25	330.38	274.33	206.53
Revenue Growth (YoY)	15.80%	16.55%	20.84%	20.43%	32.83%	-10.52%
Cost of Revenue	130.24	117.78	98.88	84.44	68.47	57.22
Gross Profit	388.06	347.52	300.37	245.94	205.86	149.31
Selling, General & Admin	304.86	291.36	257.55	231.27	204.65	150.83
Research & Development	109.66	96.18	73.92	57.34	48.51	43.07
Operating Expenses	414.52	387.54	331.47	288.61	253.16	193.9
Operating Income	-26.46	-40.01	-31.1	-42.67	-47.3	-44.59
Interest Expense	-5.83	-6.41	-6.93	-4.99	-4.92	-4.89
Interest & Investment Income	4.35	4.43	3.79	1.99	0.47	1.1
Currency Exchange Gain (Loss)	-0.33	-0.33	-0.03	-0.54	-0.37	-0.02
Other Non Operating Income (Expenses)	0.44	-	-	-	-	-
EBT Excluding Unusual Items	-27.83	-42.31	-34.26	-46.2	-52.11	-48.4
Asset Writedown	-	-	-	-	-82.3	-
Legal Settlements	-	-	4.41	-	-	-
Other Unusual Items	-	-1.36	-	-	184.8	0.36
Pretax Income	-27.83	-43.67	-29.85	-46.2	50.39	-48.04
Income Tax Expense	0.95	1.02	0.59	0.27	0.19	0.11
Net Income	-28.77	-44.7	-30.44	-46.47	50.2	-48.16
Net Income to Common	-28.77	-44.7	-30.44	-46.47	50.2	-48.16
Shares Outstanding (Basic)	48	47	46	46	45	42
Shares Outstanding (Diluted)	48	47	46	46	46	42
Shares Change (YoY)	1.59%	1.42%	1.24%	-0.65%	9.29%	12.07%
EPS (Basic)	-0.61	-0.95	-0.66	-1.02	1.11	-1.14
EPS (Diluted)	-0.61	-0.95	-0.66	-1.02	1.09	-1.14
Free Cash Flow	33	0.75	-7.51	-39.02	-23.53	-25.13
Free Cash Flow Per Share	0.69	0.02	-0.16	-0.85	-0.51	-0.60
Gross Margin	74.87%	74.69%	75.23%	74.44%	75.04%	72.29%
Operating Margin	-5.10%	-8.60%	-7.79%	-12.91%	-17.24%	-21.59%
Profit Margin	-5.55%	-9.61%	-7.62%	-14.06%	18.30%	-23.32%
Free Cash Flow Margin	6.37%	0.16%	-1.88%	-11.81%	-8.58%	-12.17%
EBITDA	-6.21	-21.28	-16.28	-30.96	-36.85	-35.04
EBITDA Margin	-1.20%	-4.57%	-4.08%	-9.37%	-13.43%	-16.97%
D&A For EBITDA	20.25	18.73	14.81	11.71	10.44	9.55
EBIT	-26.46	-40.01	-31.1	-42.67	-47.3	-44.59
EBIT Margin	-5.10%	-8.60%	-7.79%	-12.91%	-17.24%	-21.59%
Effective Tax Rate	-	-	-	-	0.37%	-
Advertising Expenses	-	2.82	1.7	1.23	0.91	0.66

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q